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1  |  INTRODUC TION
Oak is the most important cause of seasonal pollinosis in Korea. The 
overall prevalence of allergic sensitization was 45.3%, and sensi-
tization to oak was 6.6%, from 28,954 Korean adult patients in a 
retrospective study.1 Furthermore, skin reactivity to tree pollens es-
pecially to oak (4.7% to 14.4%) was significantly increased over last 
decade (about 0.28% annually).2,3 However, high cross- reactivity 
among tree pollens from the Fagales order (including oak, birch, 
alder, and hazel) often makes it difficult to identify the culprit aller-
gen. A component- resolved diagnosis using purified allergen mole-
cules can help discriminate genuine sensitization from false- positive 
reactions by cross- reaction.4 Furthermore, more clinical information 
can be obtained by comparing the sensitization pattern of patients. 
Possible further benefits include the prediction of symptom prog-
nosis and selection of patients who are more likely to be effectively 
treated by immunotherapy. Patients who are poly- sensitized to 
minor allergens are less likely to be benefited by immunotherapy.
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Abstract
Objective: The component allergens from sawtooth oak, which is a main cause of tree 
pollinosis in Korea, have not been extensively characterized except Que ac 1. This 
study was undertaken to characterize the allergenic components from sawtooth oak 
pollen and investigate the diagnostic values of each component allergen.
Methods: Transcriptomic analysis was performed to identify the birch pollen allergen 
homologues from sawtooth oak pollen. Recombinant Que ac 1, 2, 3, 6, 7, and 8 were 
produced in an E. coli expression system. IgE reactivity to each allergen was examined 
by ImmunoCAP and ELISA using the sera of 50 Korean tree pollinosis patients.
Results: Six birch pollen allergen homologues were identified using transcriptome 
analysis, as follows: Que ac 1 (54.8% identity to Bet v 1), Que ac 2 (79.7% to Bet v 2), 
Que ac 3 (24.9% to Bet v 3), 6 (71.3% to Bet v 6), Que ac 7 (80.9% to Bet v 7), and Que 
ac 8 (78.9% to Bet v 8). Que ac 1 sIgE was the most frequently recognized (84.0%), 
followed by Que ac 2 (12.0%), Que ac 3 (6.0%), and three other allergens (2.0% each). 
Que ac 1 was a dominant allergen affecting 83.7% of patients suffering from allergic 
rhinoconjunctivitis, and 92.9% of pollen food allergy syndrome patients.
Conclusion: Five novel IgE reactive components of sawtooth oak were characterized 
using transcriptome analysis. Que ac 1 is the single most important component aller-
gen of sawtooth oak pollen.
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Sawtooth oak, Quercus acutissima, showed the strongest aller-
genicity among the Korean oak species.5 Que ac 1, which is homol-
ogous to Bet v 1, was the most potent allergen from sawtooth oak 
pollen. This molecule (Que ac 1) was recognized by IgE antibodies 
from 91.3% of the oak pollinosis patients.6 However, we believe 
that there are more allergen molecules that have yet to be identi-
fied. Only four different allergen molecules from four different 
oak species are officially listed in the allergen nomenclature (www.
aller gen.org), according to the guidelines of Allergen Nomenclature 
Subcommitee of the International Union of Immunological Societies, 
as follows: Que a 1 from Q. alba7; Que m 1 from Q. mongolica8; Que i 
1 from Q. ilex9; and Que ac 1 from Q. acutissima.6 Furthermore, there 
is only one group of protein, pathogenesis- related protein 10 (PR- 
10), from oak pollen. In contrast, there are 7 allergens of different 
protein families that are described from one species of birch (Betula 
verrucosa), as follows: Bet v 1, PR- 1010; Bet v 2, profilin11; Bet v 3, 4 
EF hand polcalcin- like protein12; Bet v 4, polcalcin13; Bet v 6, phenyl 
coumaran benzylic ether reductase14; Bet v 7, cyclophilin15; Bet v 8, 
glutathione S- transferase.16
In this study, we used transcriptome analysis of sawtooth oak 
pollen to identify allergens that are homologous to birch pollen al-
lergens. Recombinant proteins were produced, and IgE reactivities 
were examined using ImmunoCAP. A plausible application of the 
component- resolved diagnosis of oak allergy was also evaluated.
2  |  SUBJEC TS AND METHODS
2.1  |  Subjects
2.1.1  |  Subjects	and	serum	samples
The serum samples were collected from 50 oak pollinosis patients 
(average 32 years, age range 7– 62 years) who visited the Allergy- 
Asthma Center at Severance Hospital, Seoul, Korea (Table S1). The 
allergy diagnosis was based on patient history and IgE tests. Specific 
IgE reactivity to white oak was determined using an ImmunoCAP 
assay (ThermoFisher Scientific). Serum sample collection was 
approved by the Institutional Review Board of Severance Hospital 
(4– 2017– 1197).
3  |  MATERIAL S AND METHODS
3.1  |  Transcriptome analysis of sawtooth oak 
pollen
Pollen grains were collected from sawtooth oak trees identified 
by a botanist. The total RNA was extracted with TRIzol reagent 
(Invitrogen) using the manufacturer's instruction. The RNA con-
centration, quality, and purity were assessed using a NanoDrop 
UV spectrophotometer (ThermoFisher Scientific) and Agilent 
Bioanalyzer Pico 6000 chip (Agilent Technologies) before sequenc-
ing. The ribosomal RNA was removed using the Illumina Ribo- Zero 
Plus rRNA Depletion kit, and the mRNA library (Illumina) was pre-
pared using the TruSeq stranded mRNA Library preparation kit 
(Illumina). The resulting library was checked with the TapeStation 
DNA1000 TapeScreen Assay (Agilent).
Cluster generation was performed immediately before sequenc-
ing on a cBot with the HiSeq® PE Cluster Kit v4- cBot. The sequencing 
was conducted using a HiSeq® SBS Kit on a HiSeq® 4000, operat-
ing with HiSeq Control Software v2.2.68 and base- calling with Real 
Time Analysis (RTA) v1.18.66.3 (Illumina). The RNA- seq contigs that 
are homologous to birch allergens (Bet v 1, 2, 3, 4, 6, 7, and 8) were 
analyzed.
3.2  |  Expression and purification of 
recombinant proteins
Que ac 2, 3, 6, 7, 8 clones were synthesized at Bioneer (Daejeon, 
Korea). The PCR- amplified DNA fragments with oligonucleotide 
(Table 1) were subcloned into the pET6xHN- N expression vector 
(Clontech Laboratories, Inc. A Takara Bio Company), which allows 
directional cloning, by the infusion method. The subcloned DNA se-
quences were determined in both directions at BioFact.
Oligonucleotide primer Sequencea 
Que ac 2 Forward TAAGGCCTCTGTCGACATGTCGTGGCAAACCTACGTC
Reverse CAGAATTCGCAAGCTTTTAGAGACCCTGATCGATGAG
Que ac 3 Forward TAAGGCCTCTGTCGACATGGCAACCAATTCAGCCCCA
Reverse CAGAATTCGCAAGCTTTCAATATTTGACAGGATATTT
Que ac 6 Forward TAAGGCCTCTGTCGACATGGAGGCAAAAAGCAAGGTC
Reverse CAGAATTCGCAAGCTTTTAGACAAACTGATTGATAAA
Que ac 7 Forward TAAGGCCTCTGTCGACATGTCAAATCCAAAGGTTTTC
Reverse CAGAATTCGCAAGCTTTCAACCGTGCAACTTCTCTAC
Que ac 8 Forward TAAGGCCTCTGTCGACATGGCTGCTGCGACCGTGAAC
Reverse CAGAATTCGCAAGCTTTCAGTGCTTAGCCAAAAAGAG
aItalicized sequences were included for the directional cloning by infusion technology.
TA B L E  1 Sequence	of	oligonucleotides	
used for directional cloning into the 
pET6xHN- N expression vector
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Each clone was transformed into Escherichia coli Rosetta- 2 (DE3) 
(Novagen). The expression was induced by adding 1 mM isopropyl- 
1- thio- β- galactopyranoside. Recombinant Que ac 2 and 3 were puri-
fied from the soluble fractions. Que ac 6, 7, and 8 were purified from 
the inclusion bodies using Ni- NTA resin (Qiagen), dialyzed against 
phosphate-	buffered	 saline	 (PBS),	 pH	 7.4,	 and	 stored	 at	 −20°C.	
Recombinant Que ac 1 was also produced by the same way as de-
scribed previously.6
In order to identify the recombinant proteins, they were con-
firmed by liquid chromatography- coupled electrospray ionization- 
tandem mass spectrometry (LC ESI MS/MS) after gel excision. In- gel 
tryptic digestion was performed for tandem mass spectrometry at 
ProteomeTech.
3.3  |  IgE reactivity of recombinant allergens
Specific IgEs to the recombinant allergens were measured using 
the ImmunoCAP platform. For ImmunoCAP analysis, biotinylation 
was performed using EZ- link® Sulfo- NHS- LC- Biotin (ThermoFisher 
Scientific). Briefly, recombinant Que ac 2, 3, 7, and 8 (2 mg) were in-
cubated with NHS- LC- biotin on ice for 4 h and then dialyzed exten-
sively against PBS to remove unreacted NHS- LC- biotin. Biotinylated 
proteins were loaded onto streptavidin ImmunoCAPs. IgE antibody 
binding to the proteins was measured using the Phadia UniCAP 100 
system according to the manufacturer's instructions. An IgE value 
≥0.35	kU/L	was	considered	positive.
IgE reactivity to recombinant Que ac 6 was examined by ELISA, 
because it was not readily biotinylated due to aggregation after di-
alysis against PBS. The microtiter plates (Corning Inc.) were coated 
with recombinant Que ac 6 (2 μg/ml in 50 mM sodium carbonate, 
pH	9.6)	and	incubated	overnight	at	4˚C.	After	blocking	with	3%	skim	
milk in PBS containing 0.05% Tween 20 (PBST), serum samples (1:4 
dilution in PBS) containing 1% bovine serum albumin were applied 
and incubated for one hour at room temperature. The IgE antibod-
ies were detected by incubating biotinylated goat anti- human IgE 
(1:1000) (Vector) for one hour, followed by incubation with strepta-
vidin peroxidase (1:1,000) (Sigma- Aldrich) for 30 min. Color was de-
veloped using TMB Microwell Peroxidase Substrate (SeraCare Life 
Science, Inc.). The absorbance at 450 nm was measured after the ad-
dition of 0.5 M H2SO4. All of the samples were duplicated. The mean 
absorbance plus double standard deviation of the negative controls 
was determined as a cutoff value.
4  |  RESULTS
4.1  |  Identification of allergen homologues by 
transcriptome analysis
We were able to identify 6 birch allergen homologous mol-
ecules (Table 2). Que ac 1 (GenBank accession No. MN201198), 2 
(MW506866), 3 (MW50686), 6 (MW506868), 7 (MW506869), and 
8 (MW506870) share 54.8% identity to Bet v 1, 79.7% to Bet v 2, 
24.9% to Bet v 3, 71.3% to Bet v 6, 80.9% to Bet v 7, and 78.9% to 
Bet v 8, respectively. However, a Bet v 4 homologous molecule was 
not found.
4.2  |  IgE reactivity and diagnostic sensitivity of the 
recombinant allergens
Six recombinant allergens were produced using the same expression 
system; pET6xHN- N vector and E. coli Rosetta- 2 (DE3) (Figure 1). The 
molecular identity of the recombinant proteins was confirmed again 
using LC ESI MS/MS (Table 3). Que ac 1 was the most frequently rec-
ognized by serum IgE (84.0%), followed by Que ac 2 (12.0%), Que ac 
3 (6.0%), and the other three allergens (2.0% each). Only the Que ac 
2 allergen was recognized by serum IgE from two patients who were 
not sensitive to Que ac 1 and increased the diagnostic sensitivity by 
4.0% (Table 4). None of the other allergens added diagnostic value to 
Que ac 1. One of Que ac 2 sensitive patients suffered from allergic 
rhinitis and PFAS, while one only had allergic rhinitis.
Notably, IgE reactivity to Que ac 1 was even stronger than IgE 
reactivity to Q. alba (t7) pollen extract, which is currently used for 
the diagnosis of oak allergy (Figure 1B).
A possible change in IgE reactivity by the structural change 
of Que ac 3 induction was examined by ELISA with 10 mM CaCl2. 
However, there was no significant change in IgE reactivity (data not 
shown).
4.3  |  Sensitization profile and disease entities
The most common symptom from oak allergy was allergic rhinosi-
nusitis (83.7%) (Table 4). Among allergic rhinosinusitis patients, 40 
(83.3%) were sensitized to Que ac 1, 7 (15.6%) to Que ac 2, 3 (6.3%) 
to Que ac 3, 1 to (2.1%) to Que ac 6, 1 to (2.1%) to Que ac 7, and 1 
to (2.1%) to Que ac 8. Six patients’ sera showed no reactivity to any 
of the six allergens.
Fourteen (28.0%) patients had pollen food allergy syndrome 
(PFAS) and 13 (92.9%) were sensitized to Que ac 1. Only one patient 
with PFAS was solely sensitized to Que ac 2 without sensitization 
to Que ac 1. Two PFAS patients were sensitized to both Que ac 1 
and 2.
5  |  DISCUSSION
We identified five new recombinant component allergens from saw-
tooth oak pollen (which is the primary sensitizer in Korea) in order 
to investigate the application of CRD in the diagnosis of oak allergy.
Not surprisingly, Que ac 1 was recognized by serum IgE in 84.0% 
of patients. Only two more patients (4.0%) could be diagnosed by Que 
ac 2, and no diagnostic value was credited to the other allergens. Que 
ac 1 was the single most potent allergen, although it had no statistical 
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correlation with a specific disease entity. Most patients (76.0%) were 
sensitized to one component allergen, 5 (10.0%) to two, 1 (2.0%) 
to 5, and 6 (12.0%) to none. Three more positives (90.0%) could be 
diagnosed if we adapted 0.1 kUA/L as cutoff value.
17 It is plausible that 
the inclusion of some Que ac 1 isoforms could increase the diagnos-
tic sensitivity since various Que ac 1 isoforms were described.6 Six 
TA B L E  2 Allergen	homologues	obtained	from	sawtooth	oak	pollen	transcriptomes
Biochemical identity Allergen Species Sequence identity
Seq 
number QueryIDa 









































































aSequences with full- sequence information are underlined.
bPutative names of sawtooth oak allergens are in the brackets.
F I G U R E  1 IgE	reactivity	to	component	allergens	from	sawtooth	oak.	Produced	recombinant	allergens	was	run	on	15%	SDS-	PAGE	(A),	and	
IgE reactivity to each allergen was assessed using the ImmunoCAP system (B)
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patients (12%) demonstrated no sensitization to the component aller-
gens test. The possibility of false positivity to white oak, which is not 
native to Korea, cannot be ruled out due to some cross- reactivity be-
tween carbohydrate determinant (CCD) and panallergens. CCD often 
causes false- positive IgE reactions without a clinical manifestation.18
Sensitization to a minor allergen component can also cause 
cross- reactivity. In particular, sensitization to polcalcin may lead to 
a diagnosis of allergy mirage.19 One of the three Que ac 3 sensitized 
patients had positive skin tests to various trees, grasses, and weed 
pollens.
TA B L E  3 Identification	of	recombinant	proteins	by	tandem	mass	analysis
Recombinant protein NCBI Blast Protein name Species Mass (Da)
Mascot 
score
Que ac 1 AFF59686.1 Bet v 1 allergen- like Quercus rubra 17,359 223
PON61986.1 Bet v 1- type allergen Parasponia andersonii 17,566 168
XP_018825721.1 Major allergen Pru ar 1- like Juglans regia 17,592 167
ACJ23862.1 Cas s 1 pollen allergen Castanea sativa 17,503 166
Que ac 2 AAW69549.1 Profilin, Cuc m 2 Cucumis melo 14,029 3,472
Q9LEI8.1 Pollen allergen Hev b 8.0204 Hevea brasiliensis 14,112 3,463
Q64LH1.1 Pollen allergen Amb a 8 Ambrosia artemisiifolia 14,218 2,556
Que ac 3 XP_023880949.1 Probable calcium- binding protein 
CML27
Quercus suber 19,753 294
PHU24259.1 Calcium- binding allergen Ole e 8 Capsicum chinense 18,462 83
XP_008356663.1 Probable calcium- binding protein 
CML27
Malus domestica 19,137 51
Que ac 6 XP_023927210.1 Isoflavone reductase homolog 
PCBER- like
Quercus suber 34,402 386
XP_010536348.1 Isoflavone reductase homolog 
P3- like
Tarenaya hassleriana 34,430 122
XP_021644235.1 Isoflavone reductase- like protein Hevea brasiliensis 33,240 106
Que ac 7 POE69746.1 Peptidyl- prolyl cis- trans 
isomerase cyp 19– 3
Quercus suber 49,763 638
XP_018823166.1 Peptidyl- prolyl cis- trans 
isomerase cyp 19– 3
Juglans regia 19,116 267
AGI78541.1 cyclophilin Suaeda sala 19,091 185
Que ac 8 XP_023893302.1 Gutathione S- transferase L3- like Quercus suber 27,086 468
XP_008359696.2 Gutathione S- transferase L3- like Malus domestica 28,439 156




IgE reactivity to component allergens (%)
Que ac 1 Que ac 2 Que ac 3 Que ac 6 Que ac 7 Que ac 8 None
Sex/age (average 32.6)
Male (average 
29.4 ± 13.3 years)
29 (58.0) 24 (82.8) 5 (17.2) 2 (6.9) 1 (3.5) 0 (0.0) 0 (0.0) 3 (10.3)
Female (average 
37.0 ± 16.7 years)
21 (42.0) 18 (85.7) 1 (4.8) 1 (4.8) 0 (0.0%) 1 (4.8) 1 (4.8) 3 (14.3)
Comorbidities
Allergic rhinitis 48 (96.0) 40 (83.3) 6 (12.5) 3 (6.3) 1 (2.1) 1 (2.1) 1 (2.1) 6 (12.5)
Allergic conjunctivitis 8 (16.0) 7 (87.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5)
Rhinoconjunctivitis 49 (98.0) 48 (98.0) 6 (12.2) 3 (6.1) 1 (2.0) 1 (2.0) 1 (2.0) 1 (2.0)
Pollen food allergy syndrome 14 (28.0) 13 (92.9) 1 (7.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Asthma 11 (22.0) 10 (91.0) 1 (9.1) 1 (9.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (9.1)
Atopic dermatitis 2 (4.0) 2 (100.0) 1 (50.0) 1 (50.0) 1 (50.0) 1 (50.0) 1 (50.0) 0 (0.0)
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Species- specific or component allergen Que ac 1- specific sensi-
tization indicates primary sensitization and is most likely to be ben-
efited by immunotherapy. However, sensitization to panallergens 
such as Que ac 2 (profilin), Que ac 3 (polcalcin- like), or Que ac 8 
(glutathione S- transferase) without sensitization to Que ac 1 implies 
non- genuine sensitization and is less likely to be suitable for immuno-
therapy. Notably, up to half of profilin sensitized patients suffer from 
PFAS to tomato, melon, watermelon, and citrus.17,20 Sensitization to 
profilin is also known to be associated with grass pollinosis.21 Among 
the five minor allergen homologues from sawtooth oak pollen, only 
Que ac 2 meets the inclusion criteria for a novel allergen. It is offi-
cially listed in the WHO/international union of the immunological 
societies allergen nomenclature subcommittee according to the 
guideline.22 Poor recognition of oak minor allergens, compared to 
birch allergens, may reflect the primary sensitization to oak pollens in 
Korea. Relatively higher percentages of sensitization to birch minor 
allergens were reported; 22% for Bet v 2, 10% for Bet v 3, 5% to Bet 
v 4, 32% to Bet v 6, 21% to Bet v 7, and 13% to Bet v 8. Studies on the 
cross- reactivity between these minor allergens from oak and birch 
allergens would be interesting. It would be useful if oak- specific or 
birch- specific allergen is characterized. Different fruit consumption 
pattern and different regional flora should be taken into account for 
better diagnosis of PFAS. Sensitization to PR- 10 molecules is mainly 
responsible for PFAS in Korea.23 Furthermore, peanut and apple are 
described as the most common culprit foods causing anaphylaxis in 
PFAS in Korea, indicating the possible role of Que ac 1, a primary 
sensitizer, which is homologous to Bet v 1.24 Molecular characteri-
zation of PR- 10 molecules from commonly consumed Korean fruits, 
such as Korean melon, ginseng, sesame leaf, deodeok, and lotus 
root,25 should be done to understand PFAS in more detail. PFAS in 
Korea should be dependent on the cross- reaction of Que ac 1 with 
homologous allergens from commonly consumed fruits. Bet v 1 and 
Que ac 1 may have different cross- reactivity to fruit allergens.
In conclusion, we characterized five new IgE reactive compo-
nents (Que ac 2, 3, 6, 7, and 8) from sawtooth oak pollen and inves-
tigated their diagnostic value. Que ac 1 and Que ac 2 are useful to 
make a diagnosis of oak pollinosis. Most IgE reactivities are directed 
to Que ac 1. However, no significant sensitization pattern was cor-
related to any allergic diseases. The recombinant allergens that were 
identified in this study will be useful to improve allergy diagnostics.
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